Jones Trading on WAVE Life Sciences (WVE) GLP-1: 'we still see the chance for utility in elderly or patients with metabolic disease'
Tweet Send to a Friend
Jones Trading analyst Catherine Novack reiterated a Buy rating and $35.00 price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
